DXCM earnings

Catalyst

DXCM earnings

DXCM earnings — 2026-07-30

Reported the quarter ending 2026-06-30: revenue $1.31B, diluted EPS $0.64, net income $249M (SEC filing). Across the print the stock moved +11.1% (close before → first close after).

Backfilled from filed financials — a record of the print, not an analyst read.

Sources

  • Financials: edgar
  • Price reaction: ohlc
7 events
DateTypeEvent
Jul 31 ScanHealthcare Scan Jul 31 ScanBiotech Scan Jul 29 CatalystDXCM earnings Jul 28 ScanHealthcare Scan Jul 28 ScanBiotech Scan Jul 25 ScanBiotech Scan Jul 25 ScanHealthcare Scan

No direct external sources are attached to this read.